Co-Chief Scientific OfficerCIK 0001796226
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Murphy Andrew JCo-Chief Scientific Officer |  REGNREGENERON PHARMACEUTICALS, INC.Gift | G | — 1,054 sh | Nov 5, 2026 traded Nov 3, 2026 | |
Murphy Andrew JCo-Chief Scientific Officer |
| REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan |
| SELL |
| $207K 271 sh |
| Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $214K 279 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $81K 105 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $167K 219 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 11 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $361K 463 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $39K 50 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 0 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Option exercise · 10b5-1 plan | M | — 17.0K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $19K 25 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $26K 35 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $12K 16 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $11K 14 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $56K 74 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $42K 55 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $9,242 12 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $94K 121 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 11 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $292K 376 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $30K 38 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 11 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $354K 454 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 16 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Option exercise · 10b5-1 plan | M | $6.49M 17.0K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 16 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Tax withholding · 10b5-1 plan | F | $9.70M 12.9K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $4,523 6 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $18K 24 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $21K 27 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $147K 192 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $98K 127 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $218K 283 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $163K 211 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $173K 224 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $51K 66 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 11 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $296K 380 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 22 | Murphy Andrew JEVP Research | REGNREGENERON PHARMACEUTICALS, INC. Tax withholding | F | $2.97M 4,229 sh | Dec 11, 2025 traded Dec 9, 2025 |
| 13 | Murphy Andrew JEVP Research | REGNREGENERON PHARMACEUTICALS, INC. Grant or award | A | — 3,715 sh | Dec 9, 2025 traded Dec 5, 2025 |
| 18 | Murphy Andrew JEVP Research | REGNREGENERON PHARMACEUTICALS, INC. Tax withholding | F | $1.21M 1,699 sh | Dec 9, 2025 traded Dec 8, 2025 |
| 9 | Murphy Andrew JEVP Research | REGNREGENERON PHARMACEUTICALS, INC. Grant or award | A | — 18.3K sh | Dec 9, 2025 traded Dec 5, 2025 |